Entering text into the input field will update the search result below

Concert Pharma EPS beats by $0.11

Nov. 07, 2019 7:11 AM ETConcert Pharmaceuticals, Inc. (CNCE) StockBy: Gaurav Batavia, SA News Editor
  • Concert Pharma (NASDAQ:CNCE): Q3 GAAP EPS of -$0.72 beats by $0.11.
  • Revenue of $0.01M (flat Y/Y)
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
CNCE--
Concert Pharmaceuticals, Inc.